Abstract
These updated guidelines are based on the first edition of the World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia published in the years 2005 and 2006. For this 2015 revision, all available publications pertaining to the biological treatment of schizophrenia were reviewed systematically to allow for an evidence-based update. These guidelines provide evidence-based practice recommendations which are clinically and scientifically relevant. They are intended to be used by all physicians diagnosing and treating patients with schizophrenia. Based on the first version of these guidelines a systematic review, as well as a data extraction from national guidelines have been performed for this update. The identified literature was evaluated with respect to the strength of evidence for its efficacy and subsequently categorised into six levels of evidence (A-F) and five levels of recommendation (1-5). This third part of the updated guidelines covers the management of the following specific treatment circumstances: comorbid depression, suicidality, various comorbid substance use disorders (legal and illegal drugs), and pregnancy and lactation. These guidelines are primarily concerned with the biological treatment (including antipsychotic medication and other pharmacological treatment options) of patients with schizophrenia.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | World Journal of Biological Psychiatry |
| Vol/bind | 16 |
| Udgave nummer | 3 |
| Sider (fra-til) | 142-70 |
| Antal sider | 29 |
| ISSN | 1562-2975 |
| DOI | |
| Status | Udgivet - 1 apr. 2015 |
FN’s Verdensmål
Dette resultat bidrager til følgende verdensmål
